Award
Delivery Order #SPE2DR26FQX9Q
Amendment for Novolog Insulin Supply to AmerisourceBergen Drug Corp
Buyer
Defense Logistics Agency
Award Amount
$5,272.80
Ceiling
$5,272.80
Awarded
February 27, 2026
Period of Performance
Feb 27, 2026 – Mar 02, 2026
Identifier
SPE2DR26FQX9Q
NAICS
424210
This award is a delivery order under an existing indefinite delivery vehicle (IDV) contract with AmerisourceBergen Drug Corporation, a leading pharmaceutical distribution company known for its comprehensive supply chain solutions. The contract secures a supply of Novolog insulin, specifically a 100 unit/ml vial in a 10ml size, essential for diabetes treatment. This delivery order supports ongoing healthcare provision by ensuring timely availability of critical pharmaceutical products. The work includes the prompt delivery of these insulin vials to the designated location in Conshohocken, Pennsylvania, within a short performance window. This procurement is part of a competitive contract vehicle designed to maintain steady pharmaceutical supplies for public health agencies. The contract was recently awarded with performance scheduled over a brief, defined period, contributing to the fulfillment of a significant long-term pharmaceutical supply framework. No additional subcontractors or prior related contracts were reported for this specific delivery order.
Description
4570982025!NOVOLOG 100 UNIT/ML VIAL 10ML